These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4721474)

  • 1. Some agonistic actions of the morphone antagonist levallorphan on behavior and brain monoamines in the rat.
    Steinert HR; Holtzman SG; Jewett RE
    Psychopharmacologia; 1973 Jul; 31(1):35-48. PubMed ID: 4721474
    [No Abstract]   [Full Text] [Related]  

  • 2. Narcotic antagonists as stimulants of behavior in the rat: specific and nonspecific effects.
    Holtzman SG
    Adv Biochem Psychopharmacol; 1973; 8(0):371-82. PubMed ID: 4794990
    [No Abstract]   [Full Text] [Related]  

  • 3. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of naloxone, chlorpromazine, and haloperidol pretreatment on levallorphan-induced disruption of rats' operant behaviour.
    Wray SR; Cowan A
    Psychopharmacologia; 1971; 22(3):261-70. PubMed ID: 5132008
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral effects of profadol in the rat.
    Holtzman SG
    Psychopharmacologia; 1974 Jan; 34(2):135-42. PubMed ID: 4818022
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems in quantification of provoked morphine withdrawal in rats].
    Herz A; Bläsig J
    Arzneimittelforschung; 1974 Jul; 24(7):1012-4. PubMed ID: 4408092
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
    Davis WM; Babbini M; Khalsa HJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of pre- and postnatal cholecystokinin treatment on brain development in rats.
    Telegdy G; Balázs M; Fekete M
    Monogr Neural Sci; 1986; 12():153-60. PubMed ID: 3642223
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible catecholamine mediation of levallorphan-induced behavioural disruption in rats.
    Wray SR
    Psychopharmacologia; 1973 Jun; 30(3):251-62. PubMed ID: 4736783
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a central stimulant substance isolated from the sea anemone Stoichactis kenti on brain monoamines of the mouse.
    Turlapaty P; Shibata S; Norton TR; Kuchii M
    Eur J Pharmacol; 1973 Dec; 24(3):359-65. PubMed ID: 4148845
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of brain amines in the behavioral depression produced by a benzoquinolizine.
    Miller FP; Maickel RP
    Life Sci; 1969 May; 8(9):487-91. PubMed ID: 5791701
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of opiate agonists, partial agonists and antagonists on brain monoamines in the rat.
    Fennessy MR; Laska FJ
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):60-70. PubMed ID: 485705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioural and brain neurohormonal changes produced by acute heat stress in rats: influence of psychopharmacological agents.
    Menon MK; Dandiya PC
    Eur J Pharmacol; 1969 Dec; 8(3):284-91. PubMed ID: 5370228
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats.
    Herz A; Bläsig J; Papeschi R
    Psychopharmacologia; 1974; 39(2):121-43. PubMed ID: 4476079
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.
    Buckett WR; Shaw JS
    Psychopharmacologia; 1975 Jun; 42(3):293-7. PubMed ID: 1172254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of early post-natal alpha-methyl-dopa treatment on behavior in the rat.
    Juvancz P; Nowaczyk T
    Psychopharmacologia; 1975 Apr; 42(1):95-7. PubMed ID: 168606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.